MENU

Statement of the DDB on the change of leadership in the Philippine Drug Enforcement Agency

The Dangerous Drugs Board welcomes the assumption of new PDEA Director General Wilkins Villanueva after Malacañang released his appointment signed last 22 May 2020. Incoming DG Villanueva has been a steadfast partner of DDB even during his early years as career officer of PDEA. DDB has involved him in many of its anti-drug efforts particularly in policy formulation and strategy development aspects which helped craft many of its inter-agency priorities all these years. Recognizing him as the 7th Director-General of PDEA, DDB intends to engage more closely and deepen the collaboration with his leadership noting that he will become an Ex-Officio Member of the Board.

Read more ...

DDB Eases the Use of Prescription Forms for Dangerous Drugs

The Dangerous Drugs Board now allows the use of ordinary prescription for medical preparations containing dangerous drugs.

Read more ...

DDB advocates for the use of electronic prescription for dangerous drugs medication

The Dangerous Drugs Board appeals to doctors, pharmacists, and drug store personnel to consider the use of electronic prescription for medicines included in the list of dangerous drugs as the whole country is under a State of Calamity due to the COVID-19 pandemic.

Read more ...

DDB, SDA Church hold program to update health directors on the Philippine Anti-Illegal Drugs Strategy (PADS) and board regulations

The Dangerous Drugs Board, in collaboration with the Southern Asia-Pacific Division of the Seventh-Day Adventist Church, convenes Luzon-based health directors of the religious group to update them on the Philippine Anti-Illegal Drugs Strategy (PADS) and relevant DDB regulations.

Read more ...

DDB clarifies: CBD is not cannabis per se

The Dangerous Drugs Board would like to clarify that marijuana use remains illegal in the country for both recreational and medical use. The use of Cannabidiol, however, is being considered to be allowed for treatment of certain rare forms of epilepsy like Lennox-Gastaut and Dravet Syndrome.

Read more ...

DDB, DOST-FNRI launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

DDB, DOST-FNRI to launch dietary manuals for Persons Who Use Drugs (PWUDs)

The Dangerous Drugs Board and the Department of Science and Technology-Food and Nutrition Research Institute, will officially launch three dietary manuals to be used in Treatment and Rehabilitation Centers (TRCs) in the Philippines.

Read more ...

PRRD reappoints Cuy as Chairperson of DDB

Secretary Catalino S. Cuy was given a fresh mandate as the Chairperson of the Dangerous Drugs Board (DDB).

This was confirmed after President Rodrigo Duterte signed his reappointment papers on 21 January 2020. Secretary Cuy was first appointed at the DDB in January 2018 serving the remainder of the term of his predecessor.

Read more ...

DDB’s response to the recommendations of the Vice President on the campaign against illegal drugs

The Dangerous Drugs Board notes the recommendations of Vice President Leni Robredo on the anti-drug campaign. The agency keeps in mind the ultimate goal of establishing drug-free communities as a serious commitment of the Duterte Administration.

Read more ...

Mapping of Drug Treatment and Rehabilitation Centers in the Philippines

This is an effort to identify and map out programs, services, modalities, clients, staffing patterns and resources and accessibility of drug treatment and rehabilitation centers in the Philippines.

An Exploratory Study on Drug Abuse among Call Center Agents in Metro Manila

Set in Metro Manila, this exploratory study aims to provide baseline information on the nature, characteristics and patterns of drug use among call center agents working in selected companies.

Respondents, purposively chosen, are call center agents in selected call centers in Metro Manila with and without experience in taking drugs. Twenty –six call center agents doing the night shift between 6 in the evening to 3 in the morning of the following day were interviewed. A Focus Group Discussion (FGD) was also conducted with call center coaches and supervisors to gather other pertinent information.

Based on the findings, it was concluded that drug use is common among call center agents. However, most of those who have tried drugs and were using it before their employment at the call centers have stopped for fear of losing their jobs or being caught.

There are some call center agents who are on drugs but compared to other professions, they are less in number. Strict measures in security implemented by the different call centers may have largely contributed to the prevention of drug use inside the call centers.

It was recommended that even if the number of drug users among call center agents is low, a drug prevention program must still be implemented. The deployment of law enforcement agents around call center companies should be made to ensure drug-free workplaces. Regular drug abuse seminars should also be conducted to remind agents of the dangers of drug abuse.

Follow-up Study on Nalbuphine Hydrochloride Abuse in the Philippines

This is a follow-up of a similar study conducted in 2005. This was undertaken to determine the incidence of Nalbuphine Hydrocholoride abuse in the country and serve as basis for policy formulation. Both the qualitative and quantitative research tools were employed in the study utilizing documentary analysis, key informant approach and focus group discussions (FGDs) with the target respondents.

Data gathering activities were undertaken in Cebu City and Zamboanga City.

Click here to view the Follow-up Study on Nalbuphine Hydrochloride